Home | NRI | Business Associates | Knowledge Bank | Careers | Back Office | Contact Us
 
 
Prospectus synopsis
 
Suraksha Diagnostic Ltd
Registered Office: Plot No DG-12/1 Action Area 1D , Premieses No 02-0327 Rajarhat , Kolkata - 700156 , West Bengal , India.
Phone:+91 33 6605 9750   Fax:
Email: investors@surakshanet.com   Website:www.surakshanet.com
Initial public offering of 19,189,330 equity shares of face value of Rs. 2 each of Suraksha Diagnostic Limited (the "Company" or the "Issuer") for cash at a price of Rs. 441 per equity share (including a premium of Rs. 439 per equity share) (the "Offer Price") aggregating to Rs. 846.25 crores through an offer for sale of 19,189,330 equity shares of face value of Rs. 2 each aggregating to Rs. 846.25 crores, comprising 2,132,148 equity shares of face value of Rs. 2 each aggregating to Rs. 94.03 crores by Somnath Chatterjee, 2,132,148 equity shares of face value of Rs. 2 each aggregating to Rs. 94.03 crores by Ritu Mittal, 2,132,148 equity shares of face value of Rs. 2 each aggregating to Rs. 94.03 crores by Satish Kumar Verma (whose shares are jointly held with Suman Verma) (together with Somnath Chatterjee and Ritu Mittal, the "Promoter Selling Shareholders"), 10,660,737 equity shares of face value of Rs. 2 each aggregating to Rs. 470.14 crores by Orbimed Asia ii Mauritius Limited^ (the "Investor Selling Shareholder"), 799,556 equity shares of face value of Rs. 2 each aggregating to Rs. 35.26 cores by Munna Lal Kejriwal, and 1,332,593 equity shares of face value of Rs. 2 each aggregating to Rs. 58.77 crores by Santosh Kumar Kejriwal (together the "Individual Selling Shareholders") (the promoter selling shareholders, the investor selling shareholder and the individual selling shareholders, collectively referred to as the "Selling Shareholders", and such equity shares offered by the selling shareholders, the "Offered Shares") (the "Offer" or the "Offer for Sale"). The offer constitutes 36.84% of the post-offer paid-up equity share capital of the company. ^ Surviving entity pursuant to amalgamation of orbimed Asia ii Mauritius fdi investments limited, the erstwhile shareholder, into orbimed asia ii mauritius limited on november 11, 2022 The face value of the equity shares is Rs. 2 each and the offer price is 220.5 times the face value of the equity shares.

Issue
Money Payable On
Opens On
Closes On
Application
Allotment
29-Nov-24 03-Dec-24 Rs 441.00-0.00 Rs 0.00-0.00
Minimum Application for shares in Nos : 34   Further Multiples of : 34


 
Rs Cr
Lead Managers to the Issue
Project Cost 0.00
ICICI Securities Ltd
Nuvama Wealth Management Ltd
SBI Capital Markets Ltd
Project Financed through Current Offer 846.25  
Post Issue Equity Share Capital 14.25  
Issue Price Rs.441.00  
 
Projects
Listing the Equity Shares on the Stock Exchanges
Promoted By
Listing At
Registrar to the Issue
 
 < Back Top
BSE Disclaimer     |     Disclaimer     |     Privacy Statement     |     Terms of Use     |     Feedback     |    Sitemap     |    Downloads    |     Client Bank Details
Useful Links   | Risk Disclosure   | Rules and Regulations   |   Investor Charter   |   Investor Complaints   |   Smart ODR   |   Attention Investors   |

SEBI Saa₹thi Mobile App/SEBI Investor Website  

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822
SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527
2006-07 © SSJ Finance & Securities Pvt. Ltd. All Rights Reserved Developed & Maintained By C-MOTS Infotech(ISO 9001:2015 certified)
Content powered by Capital Market Charts are powered by TradingView